Prediction of Tumor Mutation Burden in Breast Cancer Based on the Expression of ER, PR, HER-2, and Ki-67
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s159830
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Informa UK Limited